Cancer mutations affecting the binding affinity of protein complexes were mostly observed in several key RCC drivers, such as VHL and TCEB1, while few deleterious missense mutations were observed in other RCC drivers, such as those involved in chromatin remodeling. The gene discussed is ELOC; the disease is renal cell carcinoma.